Floatz logo

Choline Magnesium Trisalicylate

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Rutgers, The State University of New JerseyPhase 2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities cohort.

Asset / SponsorPhaseRating
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 3BBB
Cytosin-Arabinosid
Alice Mims
Phase 3BBB
Idarubicine
Bruno C. Medeiros
Phase 2BBB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 3BBB

View all 50 →

Same molecule, other indications

Choline Magnesium Trisalicylate is also rated in:

acute megakaryoblastic leukemiaDormant
CC
Indicative ·
44 / 100
View asset →
acute myeloid leukemia with minimal differentiationDormant
CC
Indicative ·
44 / 100
View asset →
acute myeloid leukemiaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →